Live Breaking News & Updates on Post Hoc Analysis From The Phase 3 Javelin Bladder 100 Trial

Stay updated with breaking news from Post hoc analysis from the phase 3 javelin bladder 100 trial . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Long-term Outcomes From JAVELIN Bladder 100 Solidify Maintenance Avelumab as SOC in Metastatic Urothelial Carcinoma

A long-term post-hoc analysis from the JAVELIN Bladder 100 trial demonstrated that first-line maintenance avelumab elicited similar overall survival and progression-free survival benefits vs best supportive care alone in patients with advanced urothelial carcinoma. ....

Srikala Sridhar , Department Of Medicine , University Of Toronto , Cancers Symposium , Cancer Clinical Research Unit , Princess Margaret Cancer Center , Genitourinary Medical Oncologists , Medical Advisory Board , Bladder Cancer Canada , New England Journal , Post Hoc Analysis From The Phase 3 Javelin Bladder 100 Trial , First Line Maintenance Avelumab , Patients With Advanced Urothelial Carcinoma , The University Of Toronto ,